Clinical prescribing summaries
Physician-targeted views — FDA-aligned dosing, indications, contraindications
These pages mirror the core fields from FDA prescribing information with editorial annotation for clinical context. Designed for quick reference in point-of-care and educational use. Not a substitute for the full PI label — always confirm against the manufacturer's official labeling.
Weight Loss
10 drugsWegovy
FDA 2021semaglutide
⚠ Boxed warning
Zepbound
FDA 2023tirzepatide
⚠ Boxed warning
Ozempic
FDA 2017semaglutide
⚠ Boxed warning
Saxenda
FDA 2014liraglutide
⚠ Boxed warning
Mounjaro
FDA 2022tirzepatide
⚠ Boxed warning
Compounded semaglutide
semaglutide (compounded)
Compounded tirzepatide
tirzepatide (compounded)
Orforglipron
FDA 2026orforglipron
⚠ Boxed warning
Rybelsus
FDA 2019semaglutide (oral)
⚠ Boxed warning
Retatrutide
retatrutide
⚠ Boxed warning
ED Treatment
2 drugsHair Loss
3 drugsFace Skincare
2 drugsRegulatory tracking
Stay current on FDA decisions, recalls, supply status, and state-level prescribing legality.